HEADER MEMBRANE PROTEIN 18-DEC-17 6BXT TITLE CRYSTAL STRUCTURE OF TOXOPLASMA GONDII MITOCHONDRIAL ASSOCIATION TITLE 2 FACTOR 1 A (MAF1A) IN COMPLEX WITH ADPRIBOSE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOCHONDRIAL ASSOCIATION FACTOR 1; COMPND 3 CHAIN: A, B, C; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TOXOPLASMA GONDII; SOURCE 3 ORGANISM_TAXID: 5811; SOURCE 4 GENE: MAF1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS MACRO DOMAIN, ADPRIBOSE, NEOFUNCTIONALIZE, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.L.PARKER,R.RAMASWAMY,M.J.BOULANGER REVDAT 4 04-OCT-23 6BXT 1 REMARK REVDAT 3 08-JAN-20 6BXT 1 REMARK REVDAT 2 20-FEB-19 6BXT 1 REMARK REVDAT 1 19-DEC-18 6BXT 0 JRNL AUTH M.L.BLANK,M.L.PARKER,R.RAMASWAMY,C.J.POWELL,E.D.ENGLISH, JRNL AUTH 2 Y.ADOMAKO-ANKOMAH,L.F.PERNAS,S.D.WORKMAN,J.C.BOOTHROYD, JRNL AUTH 3 M.J.BOULANGER,J.P.BOYLE JRNL TITL A TOXOPLASMA GONDII LOCUS REQUIRED FOR THE DIRECT JRNL TITL 2 MANIPULATION OF HOST MITOCHONDRIA HAS MAINTAINED MULTIPLE JRNL TITL 3 ANCESTRAL FUNCTIONS. JRNL REF MOL. MICROBIOL. V. 108 519 2018 JRNL REFN ESSN 1365-2958 JRNL PMID 29505111 JRNL DOI 10.1111/MMI.13947 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.40 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 3 NUMBER OF REFLECTIONS : 23084 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.235 REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.286 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.880 REMARK 3 FREE R VALUE TEST SET COUNT : 1127 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 27.3986 - 5.3880 0.92 2781 143 0.2226 0.2670 REMARK 3 2 5.3880 - 4.2819 0.98 2883 149 0.1924 0.2198 REMARK 3 3 4.2819 - 3.7422 0.87 2554 129 0.2023 0.2516 REMARK 3 4 3.7422 - 3.4007 0.97 2830 136 0.2285 0.3208 REMARK 3 5 3.4007 - 3.1573 0.97 2810 149 0.2682 0.3197 REMARK 3 6 3.1573 - 2.9714 0.98 2853 151 0.2722 0.3526 REMARK 3 7 2.9714 - 2.8228 0.96 2757 146 0.3136 0.4074 REMARK 3 8 2.8228 - 2.7000 0.86 2489 124 0.3452 0.3985 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.460 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.620 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 50.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.85 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 6213 REMARK 3 ANGLE : 0.671 8445 REMARK 3 CHIRALITY : 0.028 937 REMARK 3 PLANARITY : 0.003 1101 REMARK 3 DIHEDRAL : 13.533 2248 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6BXT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-JAN-18. REMARK 100 THE DEPOSITION ID IS D_1000231367. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-JUL-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : SIDE SCATTERING BENT CUBE-ROOT I REMARK 200 -BEAM SINGLE CRYSTAL REMARK 200 OPTICS : RH COATED FLAT REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23134 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 27.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.4 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : 0.61100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6BXS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.9 M AMMONIUM SULFATE, 0.1 M HEPES PH REMARK 280 7.0, 0.5% PEG8000, 3% 2-METHYL-2,4- PENTANEDIOL, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 24.76000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 155 REMARK 465 SER A 156 REMARK 465 MET A 157 REMARK 465 GLY A 158 REMARK 465 THR A 159 REMARK 465 PRO A 160 REMARK 465 ASP A 161 REMARK 465 ARG A 427 REMARK 465 LYS A 428 REMARK 465 TYR A 429 REMARK 465 LYS A 430 REMARK 465 PHE A 431 REMARK 465 PRO A 432 REMARK 465 GLN A 433 REMARK 465 GLY A 434 REMARK 465 ASP A 435 REMARK 465 GLY B 155 REMARK 465 SER B 156 REMARK 465 MET B 157 REMARK 465 GLY B 158 REMARK 465 THR B 159 REMARK 465 PRO B 160 REMARK 465 ASP B 161 REMARK 465 SER B 181 REMARK 465 GLY B 182 REMARK 465 ARG B 183 REMARK 465 GLN B 184 REMARK 465 ASP B 185 REMARK 465 GLY B 186 REMARK 465 ARG B 427 REMARK 465 LYS B 428 REMARK 465 TYR B 429 REMARK 465 LYS B 430 REMARK 465 PHE B 431 REMARK 465 PRO B 432 REMARK 465 GLN B 433 REMARK 465 GLY B 434 REMARK 465 ASP B 435 REMARK 465 GLY C 155 REMARK 465 SER C 156 REMARK 465 MET C 157 REMARK 465 GLY C 158 REMARK 465 THR C 159 REMARK 465 PRO C 160 REMARK 465 ASP C 161 REMARK 465 SER C 181 REMARK 465 GLY C 182 REMARK 465 ARG C 183 REMARK 465 GLN C 184 REMARK 465 ASP C 185 REMARK 465 GLY C 186 REMARK 465 ARG C 229 REMARK 465 ARG C 230 REMARK 465 ASN C 231 REMARK 465 ARG C 232 REMARK 465 ILE C 233 REMARK 465 PRO C 234 REMARK 465 ARG C 427 REMARK 465 LYS C 428 REMARK 465 TYR C 429 REMARK 465 LYS C 430 REMARK 465 PHE C 431 REMARK 465 PRO C 432 REMARK 465 GLN C 433 REMARK 465 GLY C 434 REMARK 465 ASP C 435 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O TYR A 354 OG1 THR A 357 2.10 REMARK 500 NH1 ARG C 198 OD1 ASP C 319 2.16 REMARK 500 O VAL B 214 O1D APR B 501 2.17 REMARK 500 NH1 ARG B 198 OD1 ASP B 319 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE1 GLN A 184 NH1 ARG C 420 2746 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 214 -159.37 -123.46 REMARK 500 THR A 287 -66.23 -121.40 REMARK 500 HIS A 313 18.61 59.43 REMARK 500 LYS A 363 68.76 -111.56 REMARK 500 ALA B 204 82.50 -65.80 REMARK 500 PHE B 270 17.73 -150.53 REMARK 500 TRP B 289 -169.26 -117.03 REMARK 500 LYS B 363 73.16 -117.68 REMARK 500 VAL C 273 -60.92 -106.86 REMARK 500 LYS C 363 73.72 -118.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue APR A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue APR B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6BXS RELATED DB: PDB REMARK 900 6BXS CONTAINS THE SAME PROTEIN COMPLEXED WITH ADP-RIBOSE DBREF1 6BXT A 159 435 UNP A0A193AUK9_TOXGO DBREF2 6BXT A A0A193AUK9 159 435 DBREF1 6BXT B 159 435 UNP A0A193AUK9_TOXGO DBREF2 6BXT B A0A193AUK9 159 435 DBREF1 6BXT C 159 435 UNP A0A193AUK9_TOXGO DBREF2 6BXT C A0A193AUK9 159 435 SEQADV 6BXT GLY A 155 UNP A0A193AUK EXPRESSION TAG SEQADV 6BXT SER A 156 UNP A0A193AUK EXPRESSION TAG SEQADV 6BXT MET A 157 UNP A0A193AUK EXPRESSION TAG SEQADV 6BXT GLY A 158 UNP A0A193AUK EXPRESSION TAG SEQADV 6BXT GLY B 155 UNP A0A193AUK EXPRESSION TAG SEQADV 6BXT SER B 156 UNP A0A193AUK EXPRESSION TAG SEQADV 6BXT MET B 157 UNP A0A193AUK EXPRESSION TAG SEQADV 6BXT GLY B 158 UNP A0A193AUK EXPRESSION TAG SEQADV 6BXT GLY C 155 UNP A0A193AUK EXPRESSION TAG SEQADV 6BXT SER C 156 UNP A0A193AUK EXPRESSION TAG SEQADV 6BXT MET C 157 UNP A0A193AUK EXPRESSION TAG SEQADV 6BXT GLY C 158 UNP A0A193AUK EXPRESSION TAG SEQRES 1 A 281 GLY SER MET GLY THR PRO ASP PRO LEU THR LEU ARG PHE SEQRES 2 A 281 THR CYS LEU GLY ASP ARG ASN VAL ILE PHE PHE GLY PRO SEQRES 3 A 281 SER GLY ARG GLN ASP GLY PHE THR PRO LEU TYR ASP PRO SEQRES 4 A 281 SER PRO SER LYS ARG VAL ALA THR VAL ASP ALA GLY THR SEQRES 5 A 281 TYR GLY LEU PHE ILE GLY GLY VAL GLY MET ASN GLY GLU SEQRES 6 A 281 PHE ALA ASP THR ILE ILE GLU GLU ALA ARG ARG ASN ARG SEQRES 7 A 281 ILE PRO LEU THR ALA THR GLU LEU SER ALA GLU SER GLN SEQRES 8 A 281 GLU ILE GLN GLU ARG LEU LEU HIS ASP ALA GLU ARG GLN SEQRES 9 A 281 PRO GLY THR LEU VAL GLU ILE ASP SER GLY ARG PHE SER SEQRES 10 A 281 ARG VAL PHE ALA ARG SER PHE ALA TYR VAL ALA ILE VAL SEQRES 11 A 281 PRO ASN THR VAL TRP ASP GLU SER GLU THR GLY LYS ASN SEQRES 12 A 281 VAL GLY ALA THR PHE LEU HIS ILE LEU LYS PRO GLU VAL SEQRES 13 A 281 THR PRO HIS GLY ASN GLU MET ASN ASP VAL MET LEU TYR SEQRES 14 A 281 THR VAL ALA PRO PHE GLY ASN ALA SER ASP SER ALA TYR SEQRES 15 A 281 ASN MET ALA TYR LYS ALA THR MET LEU GLY ILE VAL GLY SEQRES 16 A 281 ALA VAL SER GLU TYR ASN LYS THR PRO TRP GLY GLU VAL SEQRES 17 A 281 LYS PRO VAL GLU ALA ILE ARG LEU PRO LEU LEU GLY ALA SEQRES 18 A 281 GLY HIS PHE ARG GLY ARG ARG GLY LEU HIS SER ILE GLY SEQRES 19 A 281 ARG ALA ASN ALA VAL ALA VAL GLU ALA ALA ILE THR ARG SEQRES 20 A 281 PHE ASP PRO ARG VAL GLU LEU GLN PHE MET TYR GLU PRO SEQRES 21 A 281 SER ASP THR ALA LEU ARG GLY LEU MET GLU SER GLU ARG SEQRES 22 A 281 LYS TYR LYS PHE PRO GLN GLY ASP SEQRES 1 B 281 GLY SER MET GLY THR PRO ASP PRO LEU THR LEU ARG PHE SEQRES 2 B 281 THR CYS LEU GLY ASP ARG ASN VAL ILE PHE PHE GLY PRO SEQRES 3 B 281 SER GLY ARG GLN ASP GLY PHE THR PRO LEU TYR ASP PRO SEQRES 4 B 281 SER PRO SER LYS ARG VAL ALA THR VAL ASP ALA GLY THR SEQRES 5 B 281 TYR GLY LEU PHE ILE GLY GLY VAL GLY MET ASN GLY GLU SEQRES 6 B 281 PHE ALA ASP THR ILE ILE GLU GLU ALA ARG ARG ASN ARG SEQRES 7 B 281 ILE PRO LEU THR ALA THR GLU LEU SER ALA GLU SER GLN SEQRES 8 B 281 GLU ILE GLN GLU ARG LEU LEU HIS ASP ALA GLU ARG GLN SEQRES 9 B 281 PRO GLY THR LEU VAL GLU ILE ASP SER GLY ARG PHE SER SEQRES 10 B 281 ARG VAL PHE ALA ARG SER PHE ALA TYR VAL ALA ILE VAL SEQRES 11 B 281 PRO ASN THR VAL TRP ASP GLU SER GLU THR GLY LYS ASN SEQRES 12 B 281 VAL GLY ALA THR PHE LEU HIS ILE LEU LYS PRO GLU VAL SEQRES 13 B 281 THR PRO HIS GLY ASN GLU MET ASN ASP VAL MET LEU TYR SEQRES 14 B 281 THR VAL ALA PRO PHE GLY ASN ALA SER ASP SER ALA TYR SEQRES 15 B 281 ASN MET ALA TYR LYS ALA THR MET LEU GLY ILE VAL GLY SEQRES 16 B 281 ALA VAL SER GLU TYR ASN LYS THR PRO TRP GLY GLU VAL SEQRES 17 B 281 LYS PRO VAL GLU ALA ILE ARG LEU PRO LEU LEU GLY ALA SEQRES 18 B 281 GLY HIS PHE ARG GLY ARG ARG GLY LEU HIS SER ILE GLY SEQRES 19 B 281 ARG ALA ASN ALA VAL ALA VAL GLU ALA ALA ILE THR ARG SEQRES 20 B 281 PHE ASP PRO ARG VAL GLU LEU GLN PHE MET TYR GLU PRO SEQRES 21 B 281 SER ASP THR ALA LEU ARG GLY LEU MET GLU SER GLU ARG SEQRES 22 B 281 LYS TYR LYS PHE PRO GLN GLY ASP SEQRES 1 C 281 GLY SER MET GLY THR PRO ASP PRO LEU THR LEU ARG PHE SEQRES 2 C 281 THR CYS LEU GLY ASP ARG ASN VAL ILE PHE PHE GLY PRO SEQRES 3 C 281 SER GLY ARG GLN ASP GLY PHE THR PRO LEU TYR ASP PRO SEQRES 4 C 281 SER PRO SER LYS ARG VAL ALA THR VAL ASP ALA GLY THR SEQRES 5 C 281 TYR GLY LEU PHE ILE GLY GLY VAL GLY MET ASN GLY GLU SEQRES 6 C 281 PHE ALA ASP THR ILE ILE GLU GLU ALA ARG ARG ASN ARG SEQRES 7 C 281 ILE PRO LEU THR ALA THR GLU LEU SER ALA GLU SER GLN SEQRES 8 C 281 GLU ILE GLN GLU ARG LEU LEU HIS ASP ALA GLU ARG GLN SEQRES 9 C 281 PRO GLY THR LEU VAL GLU ILE ASP SER GLY ARG PHE SER SEQRES 10 C 281 ARG VAL PHE ALA ARG SER PHE ALA TYR VAL ALA ILE VAL SEQRES 11 C 281 PRO ASN THR VAL TRP ASP GLU SER GLU THR GLY LYS ASN SEQRES 12 C 281 VAL GLY ALA THR PHE LEU HIS ILE LEU LYS PRO GLU VAL SEQRES 13 C 281 THR PRO HIS GLY ASN GLU MET ASN ASP VAL MET LEU TYR SEQRES 14 C 281 THR VAL ALA PRO PHE GLY ASN ALA SER ASP SER ALA TYR SEQRES 15 C 281 ASN MET ALA TYR LYS ALA THR MET LEU GLY ILE VAL GLY SEQRES 16 C 281 ALA VAL SER GLU TYR ASN LYS THR PRO TRP GLY GLU VAL SEQRES 17 C 281 LYS PRO VAL GLU ALA ILE ARG LEU PRO LEU LEU GLY ALA SEQRES 18 C 281 GLY HIS PHE ARG GLY ARG ARG GLY LEU HIS SER ILE GLY SEQRES 19 C 281 ARG ALA ASN ALA VAL ALA VAL GLU ALA ALA ILE THR ARG SEQRES 20 C 281 PHE ASP PRO ARG VAL GLU LEU GLN PHE MET TYR GLU PRO SEQRES 21 C 281 SER ASP THR ALA LEU ARG GLY LEU MET GLU SER GLU ARG SEQRES 22 C 281 LYS TYR LYS PHE PRO GLN GLY ASP HET APR A 501 36 HET APR B 501 36 HETNAM APR ADENOSINE-5-DIPHOSPHORIBOSE FORMUL 4 APR 2(C15 H23 N5 O14 P2) FORMUL 6 HOH *16(H2 O) HELIX 1 AA1 VAL A 214 ASN A 231 1 18 HELIX 2 AA2 THR A 236 GLN A 258 1 23 HELIX 3 AA3 ASP A 266 PHE A 270 5 5 HELIX 4 AA4 ASP A 290 GLY A 295 1 6 HELIX 5 AA5 PRO A 308 ASN A 318 5 11 HELIX 6 AA6 SER A 332 LYS A 356 1 25 HELIX 7 AA7 THR A 357 LYS A 363 1 7 HELIX 8 AA8 GLY A 383 ASP A 403 1 21 HELIX 9 AA9 ASP A 416 GLU A 426 1 11 HELIX 10 AB1 VAL B 214 ASN B 231 1 18 HELIX 11 AB2 THR B 236 GLN B 258 1 23 HELIX 12 AB3 ASP B 266 PHE B 270 5 5 HELIX 13 AB4 ASP B 290 GLY B 295 1 6 HELIX 14 AB5 THR B 311 ASN B 318 5 8 HELIX 15 AB6 SER B 332 THR B 357 1 26 HELIX 16 AB7 THR B 357 LYS B 363 1 7 HELIX 17 AB8 GLY B 383 ASP B 403 1 21 HELIX 18 AB9 ASP B 416 GLU B 426 1 11 HELIX 19 AC1 THR C 168 GLY C 171 5 4 HELIX 20 AC2 VAL C 214 ALA C 228 1 15 HELIX 21 AC3 THR C 236 GLN C 258 1 23 HELIX 22 AC4 ASP C 266 SER C 271 5 6 HELIX 23 AC5 ASP C 290 GLY C 295 1 6 HELIX 24 AC6 THR C 311 ASN C 318 5 8 HELIX 25 AC7 SER C 332 THR C 357 1 26 HELIX 26 AC8 THR C 357 LYS C 363 1 7 HELIX 27 AC9 GLY C 383 ASP C 403 1 21 HELIX 28 AD1 ASP C 416 GLU C 426 1 11 SHEET 1 AA1 9 LEU A 163 PHE A 167 0 SHEET 2 AA1 9 ARG A 173 PHE A 177 -1 O VAL A 175 N LEU A 165 SHEET 3 AA1 9 GLU A 407 PHE A 410 1 O LEU A 408 N ILE A 176 SHEET 4 AA1 9 ALA A 367 LEU A 370 1 N LEU A 370 O GLN A 409 SHEET 5 AA1 9 VAL A 199 GLY A 205 1 N VAL A 202 O ARG A 369 SHEET 6 AA1 9 VAL A 320 VAL A 325 1 O LEU A 322 N ASP A 203 SHEET 7 AA1 9 THR A 301 LEU A 306 -1 N PHE A 302 O TYR A 323 SHEET 8 AA1 9 PHE A 274 TYR A 280 -1 N ARG A 276 O ILE A 305 SHEET 9 AA1 9 VAL A 263 ILE A 265 -1 N ILE A 265 O SER A 277 SHEET 1 AA2 9 LEU B 163 PHE B 167 0 SHEET 2 AA2 9 ARG B 173 PHE B 177 -1 O VAL B 175 N LEU B 165 SHEET 3 AA2 9 GLU B 407 PHE B 410 1 O LEU B 408 N ILE B 176 SHEET 4 AA2 9 ALA B 367 LEU B 370 1 N LEU B 370 O GLN B 409 SHEET 5 AA2 9 VAL B 199 ALA B 204 1 N VAL B 202 O ARG B 369 SHEET 6 AA2 9 VAL B 320 THR B 324 1 O LEU B 322 N THR B 201 SHEET 7 AA2 9 THR B 301 LEU B 306 -1 N PHE B 302 O TYR B 323 SHEET 8 AA2 9 PHE B 274 TYR B 280 -1 N ALA B 275 O ILE B 305 SHEET 9 AA2 9 LEU B 262 ILE B 265 -1 N ILE B 265 O SER B 277 SHEET 1 AA3 9 LEU C 163 PHE C 167 0 SHEET 2 AA3 9 ARG C 173 PHE C 177 -1 O ARG C 173 N PHE C 167 SHEET 3 AA3 9 GLU C 407 PHE C 410 1 O PHE C 410 N ILE C 176 SHEET 4 AA3 9 ALA C 367 LEU C 370 1 N LEU C 370 O GLN C 409 SHEET 5 AA3 9 VAL C 199 ALA C 204 1 N VAL C 202 O ARG C 369 SHEET 6 AA3 9 VAL C 320 THR C 324 1 O LEU C 322 N ASP C 203 SHEET 7 AA3 9 THR C 301 LEU C 306 -1 N PHE C 302 O TYR C 323 SHEET 8 AA3 9 PHE C 274 TYR C 280 -1 N ARG C 276 O ILE C 305 SHEET 9 AA3 9 VAL C 263 ILE C 265 -1 N VAL C 263 O ALA C 279 SITE 1 AC1 16 PHE A 187 ALA A 204 THR A 206 VAL A 214 SITE 2 AC1 16 GLY A 215 MET A 216 ASN A 217 GLU A 219 SITE 3 AC1 16 PRO A 371 LEU A 372 GLY A 374 GLY A 376 SITE 4 AC1 16 HIS A 377 PHE A 378 MET A 411 HOH A 601 SITE 1 AC2 16 PHE B 187 ALA B 204 GLY B 205 THR B 206 SITE 2 AC2 16 VAL B 214 GLY B 215 MET B 216 ASN B 217 SITE 3 AC2 16 GLU B 219 LEU B 372 GLY B 374 ALA B 375 SITE 4 AC2 16 GLY B 376 HIS B 377 PHE B 378 GLU B 413 CRYST1 78.230 49.520 115.710 90.00 96.63 90.00 P 1 21 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012783 0.000000 0.001486 0.00000 SCALE2 0.000000 0.020194 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008700 0.00000